Dr. Ajay Goel on Blood-Based Screening and the Next Frontier of Cancer Prevention

In this episode, Ajay Goel, PhD, AGAF, Professor and Chair, Department of Molecular Diagnostics and Experimental Therapeutics, City of Hope, discusses a promising blood-based test that detected 81% of advanced precancerous colorectal lesions and explores how earlier detection could shift cancer care toward prevention. He also examines screening access, reimbursement, follow-up care and the growing role of liquid biopsies in the future of oncology.